Tamper-Resistant Hydrocodone Drug Has Successful Clinical Trial

Share on Facebook
Stamford, Conn.-based Purdue Pharma, the manufacturer of OxyContin, announced successful results from a stage three clinical trial on its hydrocodone drug designed to prevent misuse and abuse of the drug.

Read the full article on Becker's Hospital Review.

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


New from Becker's ASC Review

Bringing Higher Acuity Cases Into ASCs: What is Making this Possible?

Read Now